Global anesthetics market projected to reach $12.1 billion by 2028 due to rising surgeries demand.
From GlobeNewswire: 2024-04-04 11:30:00
The global anesthetics market is experiencing robust growth, projected to reach $9.77 billion in 2024 and $12.1 billion by 2028. This growth is fueled by lifestyle-related diseases like obesity and diabetes, driving the need for surgical interventions and anesthetics. Companies are launching new products to meet increasing demand, with North America leading the market.
The rise in lifestyle-related diseases is fueling the growth of the anesthetics market, projected to double to $12.1 billion by 2028. Anesthetics are in high demand due to the global increase in surgeries, with key players launching new products like Avet Pharmaceuticals Inc.’s Propofol Injectable Emulsion, USP 10 mg/mL, making anesthesia more accessible and affordable.
Key market players in the anesthetics market are focusing on product innovations to meet the increasing demand for surgical interventions driven by rising lifestyle-related diseases. With North America leading the market share in 2023, regions like Asia Pacific and Western Europe are also witnessing significant growth opportunities. The market is segmented based on type, route of administration, and geography, with general anesthetics and intravenous anesthesia drugs showing substantial growth potential.
North America currently dominates the anesthetics market, but other regions like Asia Pacific and Western Europe are experiencing significant growth opportunities. Key companies in the market are launching new products to cater to the increasing demand for anesthetics driven by lifestyle-related diseases like obesity and diabetes. The market is segmented based on type, route of administration, and geography, with general anesthetics and intravenous anesthesia drugs showing promising growth.
Read more at GlobeNewswire: Anesthetics Market Growth Forecast 2024-2028: Market Size